BD1.AX - BARD1 Life Sciences Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
All numbers in thousands
Revenue30/06/201830/06/201730/06/201631/12/2015
Total revenue265.99339.824--
Cost of revenue951.6961,221.163--
Gross profit-685.703-1,181.339--
Operating expenses
Research development----
Selling general and administrative1,144.3291,276.921246.87264.446
Non-recurring----
Others----
Total operating expenses2,137.622,531.092255.37885.269
Operating income or loss-1,871.627-2,491.268-255.378-85.269
Income from continuing operations
Total other income/expenses net54.326-112.903-5,426.808-
Earnings before interest and taxes-1,871.627-2,491.268-255.378-85.269
Interest expense----
Income before tax-1,817.301-2,604.171-5,682.186-85.269
Income tax expense----
Minority interest----
Net income from continuing ops-1,817.301-2,604.171-5,682.186-85.269
Non-recurring events
Discontinued operations----
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income-1,817.301-2,604.171-5,682.186-85.269
Preferred stock and other adjustments----
Net income applicable to common shares-1,817.301-2,604.171-5,682.186-85.269